FDA Inspection
Southern Eye BankSouthern Eye Bank – FDA Inspection, Apr 13, 2017
Record Details
This FDA Inspection record concerns Southern Eye Bank, with an inspection on April 13, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · a6719193-a12d-41a8-935e-c7a8294229fb
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1010185
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
- Outcome
- Form 483 issued
Other FDA inspections of Southern Eye Bank
5| Date | Classification | Office | Project area |
|---|---|---|---|
| March 6, 2026 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| May 25, 2023 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| April 8, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 16, 2014 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| August 25, 2010 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Southern Eye Bank
- FDA Inspection 1307916 - 2026-03-06
- FDA Inspection 1208214 - 2023-05-25
- FDA Inspection 1095564 - 2019-04-08
- FDA Inspection 863714 - 2014-01-16
- FDA Inspection 678735 - 2010-08-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.